This compound is a protected nucleoside analog intermediate featuring a difluoro-substituted ribose core with benzoyl ester protecting groups. It is primarily used in the synthesis of modified nucleoside analogs for pharmaceutical research and development.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 134790-39-9
2-Deoxy-2,2-difluoro-alpha-D-erythro-pentofuranose 3,5-dibenzoate 1-methanesulfonate
pharmaceutical intermediate
2-Deoxy-alpha-D-erythropentofuranose 1-acetate 3,5-bis(4-chlorobenzoate)
pharmaceutical intermediate
1-(3-C-Acetyl-2,7-dideoxy-2-fluoroheptofuranosyl-6-ulose)pyrimidine-2,4(1H,3H)-dione
pharmaceutical intermediate
6-(Benzyloxy)-9-[(1S,3R,4S)-2-methylene-4-(phenylmethoxy)-3-[(phenylmethoxy)methyl]cyclopentyl]-9H-purine-2-amine
pharmaceutical intermediate
1-(2-Methoxyethyl)piperazine
pharmaceutical intermediate
1-(4-(1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)vinyl)phenyl)ethanone
pharmaceutical intermediate
2-(2-(2-Aminoethoxy)ethoxy)acetic acid hydrochloride
pharmaceutical intermediate
Pseudotropine
pharmaceutical intermediate
[(2R,3R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3-benzoyloxy-4,4-difluorooxolan-2-yl]methyl benzoate
ZPUUYUUQQGBHBU-HGHGUNKESA-N
C1=CC=C(C=C1)C(=O)OC[C@@H]2[C@H](C([C@@H](O2)N3C=CC(=NC3=O)N)(F)F)OC(=O)C4=CC=CC=C4